News
-
State finalists named
Wednesday | Jul 26 2017SEMI-FINALISTS in the Pharmacy Guild of Australia's National Student Business Plan Competition have been announced.
-
Orphan additions
Wednesday | Jul 26 2017EMERGE Health's Nitisinone (Disanit) for hereditary tyrosinemia type-1 has been granted designated orphan status by the Therapeutic Goods Administration.
-
Biologics review
Wednesday | Jul 26 2017THE Pharmaceutical Benefits Advisory Committee (PBAC) has recommended a post market review of etanercept biologic alternatives for treatment of severe chronic plaque psoriasis.
-
Umab label changes
Wednesday | Jul 26 2017THE US Food and Drug Administration (FDA) has said it is considering labeling changes to include additional ocular inflammatory conditions for three immune checkpoint inhibitors.
-
Sigma, Chemist Warehouse progress
Wednesday | Jul 26 2017SIGMA Healthcare Limited this morning confirmed it had entered into a "formal negotiation period" with My Chemist/Chemist Warehouse Group with the aim of seeking a commercial resolution of issues under dispute.
-
Preventable hospital bed-days top 2.7m
Wednesday | Jul 26 2017WHILE people in developing countries struggle to access vaccines for themselves and their children, in Australia, where vaccines are freely available, there have been more than 2.7 million hospital bed-days billed to the taxpayer.
-
Hazardous workshop
Wednesday | Jul 26 2017A pre-conference workshop on understanding and treating hazardous drug use will take place in the lead-up to the upcoming Pharmacy Connect conference.
-
TGA fake drug alerts
Wednesday | Jul 26 2017THE Therapeutic Goods administration has warned that RUFF Natural Formula capsules, which contain tadalafil, sildenafil and dapoxetine, as well as Sirrori Green Viagra Tablets which contain sildenafil, pose a serious risk to health.
-
TGA explains codeine danger
Wednesday | Jul 26 2017THE Therapeutic Goods Administration has expanded the information available at its online 'Codeine Hub' (PD 14 Jul), with additional resources available under the heading 'Codeine use can be harmful'.
-
Blooms Health ad banned
Wednesday | Jul 26 2017BLOOMS Health has been pinged for promoting online its Coenzyme Q10 150 Max product (pictured) as an "amazing" panacea across a wide range of medical conditions, by the Therapeutic Goods Administration Complaints Resolution Panel (TGACRP).
